INTRODUCTION
Mitochondrial and nucleo-cytosolic compartments of eukaryotic cells are in a permanent cross-talk (1) . Mitochondrial DNA (mtDNA) codes for only a small subset of macromolecules residing in the organelle, whereas the majority of proteins and some small RNAs are expressed from nuclear genes and targeted into mitochondria (2, 3) . Import of nuclear-encoded RNAs into the mitochondrial matrix can now be considered as an universal process. Indeed, found in a variety of biological systems, it appears to be a fundamental mechanism of intercompartmental targeting of macromolecules, along with other pathways better characterized, like protein delivery to mitochondria, chloroplasts or peroxisomes. The mechanism of RNA mitochondrial import has been largely addressed in the past few years in four main models: yeast and human Human Molecular Genetics, Vol. 13, No. 20 # Oxford University Press 2004; all rights reserved { The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors. *To whom correspondence should be addressed: Tel: þ33 390241481; Fax: þ33 388417070; Email: i.tarassov@ibmc.u-strasbg.fr Human Molecular Genetics, 2004, Vol. 13, No. 20 2519-2534 doi:10.1093/hmg/ddh267 Advance Access published on August 18, 2004 cells (in our group, reviewed in 3), trypanosomatids (4 -10) and plants (11 -13) . The mechanisms have some similarity, especially with respect to energetic and physico-chemical requirements in all different organisms. On the other hand, the requirement of targeting factors is different: in yeast and human cells aminoacyl-tRNA synthetases were shown to be involved as essential import factors (14, 15) , in plants these enzymes may also be involved but rather as specificity factors (11, 12) , whereas in trypanosomatids no soluble factors seem to be involved (5, 6) . Mitochondrial receptors are also distinct: in yeast and human cells the pre-protein import apparatus is clearly involved (15, 16) , whereas in trypanosomes protein and RNA import seem to be independent (7, 17) .
In the yeast Saccharomyces cerevisiae, a subpopulation of the cytosolic tRNA CUU Lys (hereafter, tK1) is imported into mitochondria, the second yeast cytosolic tRNA UUU Lys (tK2) is not imported, whereas mtDNA codes for the third tRNA UUU Lys (tK3) (18) . In human cells, tRNAs are normally not imported (as all mt-tRNAs required for mitochondrial translation are encoded in the mitochondrial genome), whereas other small RNA species (5S rRNA, MRP RNase and RNase P RNA components) have been reported to be mitochondrially targeted (19, 20) . We previously found that yeast tK1, mutant versions of tK2 and the synthetic transcript of tK3 could be imported into isolated human mitochondria (15) .
In yeast, two aminoacyl-tRNA synthetases are involved in tK1 targeting into mitochondria: the cytosolic lysyl-tRNA synthetase KRS1p aminoacylates the tRNA prior to the import, whereas the cytosolic precursor of the mitochondrial enzyme, pre-MSK1p, serves as the carrier/targeting factor to deliver the tRNA to the organelle (3, 14, 21) . Import of tRNAs into isolated human mitochondria was found to be dependent on soluble proteins (22) and yeast protein extracts can be replaced by human cell extract (15) , suggesting that human cells possess a cryptic tRNA import mechanism. When yeast tRNA Lys derivatives were imported into isolated human mitochondria, it was suggested (on the basis of immunodepletion experiments) that the human counterpart of the preMSK1p was able to replace the yeast protein without loss of import specificity (15) .
RNA import pathways revealed a high degree of flexibility, permitting the RNAs from one organism to be imported into mitochondria of another (for example, yeast tRNAs in human mitochondria, yeast tRNAs in trypanosomatid ones, tRNAs from one plant species into the mitochondria of another plant, where they are not normally imported) (3, 23) . We have shown previously that one can import into yeast and human mitochondria mutant versions of cytosolic tRNAs that are normally not imported (tK2-variants), tRNAs that are normally encoded in mtDNA (tK3), as well as tRNAs that had altered aminoacylation and decoding properties [tK1cau, aminoacylated with methionine; tK1/2(G3:U70) versions aminoacylated with alanine; tK1/2cua versions able to decode amber stop codons] (3, 24) . Such flexibility leads us to propose that the RNA import pathway could be exploited to rescue dysfunctions associated with mt-tRNA mutations in humans. We previously proved the possibility of such complementation in yeasts (22) , and in the present study aimed to demonstrate that such rescue may be achieved in human cells.
More than 200 mutations in human mtDNA have been associated with neurodegenerative and muscular pathologies (25 -27) . As a model, we have chosen the A8344G MERRF (myoclonic epilepsy with ragged-red fibres) mutation affecting the mt-tRNA Lys gene and localized in the T-arm of the tRNA, which is one of the best-studied and relatively common pathological mutations in human mtDNA (28, 29) . The A8344G mutation has been reported to cause poor aminoacylation of the mutant tRNA (30) , hypomodification of its anticodon wobble-position (31) and premature termination of translation at some lysine codons (30) , all of which result in decreased activities of respiratory complexes I and IV, low respiration rate and decreased potential across the mitochondrial inner membrane (32) . We demonstrate here for transmitochondrial cybrid cells and primary fibroblasts that import tRNA Lys derivatives from cytosol into mitochondria may partially rescue all the mitochondrial functions affected by the MERRF mutation.
RESULTS

Expression of yeast tRNA Lys versions in immortalized human cells
We previously found that tK1, several of its mutant versions, mutant versions of tK2 and the synthetic transcript of tK3 could be imported into isolated human mitochondria (15, 24) . We tested whether the import could be reproduced in cultured human cells for three tK derivatives shown to be imported in vitro. Genes encoding a mutant version of tK1 (tK1cau), tK3 and a mutant version of tK2 (tK93) (Fig. 1A) were cloned into a mammalian expression vector pBK-CMV. Following stable transfection of human HepG2 cells, tK1cau, tK93 and tK3 expression was detected by northern hybridization (Fig. 1B -D) . pBK-CMV vector was uniquely used for introducing the tRNA genes in the cell, but not their expression directed from the CMV promotor, since tRNA genes are transcribed by RNA polymerase III (RpoIII) in the nucleus, and by mitochondrial RNA polymerase (mtRpo) in mitochondria (33) . The genes encoding both human and yeast cytosolic tRNAs possess conserved blocks (T-and D-motifs) which constitute the internal promoter for RpoIII (34, 35) . Therefore, tK1cau and tK93 versions of cytosolic yeast tRNA genes may be transcribed by the host RpoIII in human cells. In contrast, tK3 is coded for by mtDNA in yeast. Fortunately, tK3 sequence revealed the presence of sequence motifs very similar to the conserved blocks of RpoIII internal promoter. To be more affirmative, one can suggest using specific inhibitors of RpoII and III to distinguish between the two polymerases. However, taking into account that the tRNA genes were cloned in an opposite direction when compared with the CMV promoter, one can suggest that tK93, tK1cau and tK3 were expressed by the human RpoIII, and not by the host RpoII. Comparison of gel migration of tK1cau, tK93 and tK3 isolated from yeast and human cells revealed no detectable difference (data not shown), therefore, we suggest that yeast tRNA derivatives were correctly processed in human cells.
In agreement with the in vitro data, a fraction of the sucessfully expressed transgenic tRNAs were localized in highly purified mitochondria. Since purification included the step of mitoplast generation (removal of the outer membrane), the most probable localization of the tK version was the mitochondrial matrix, where host mtRNAs normally reside. Real-time RT -PCR revealed that 2-5% of the total cellular pool of tK versions was associated with the mitochondrial compartment of the cell. Taking into account the importance of the carrier protein, pre-MSK1p, for tK1 import into yeast mitochondria, all three versions were tested in human cells either alone, or in the presence of the pre-MSK1p-coding gene on the same plasmid. For versions tK3 and tK1cau, the import efficiency was reproducibly 30-40% higher in the presence of the MSK1 gene, whereas there was no reproducible effect of MSK1 coexpression on tK93 import (Fig. 1B -D) . This result is in agreement with our previous in vitro data and suggests that pre-MSK1p may be dispensable for import in human mitochondria. However, taking into account a clear positive effect of MSK1 coexpression on import efficiency of at least some of the versions, for all further experiments, MSK1-containing constructs were used. These results are in agreement with our previous in vitro data and demonstrate that a cryptic tRNA import mechanism can be activated in human cells by a simple expression of a suitable tRNA version. It is clear, however, that the detailed mechanism remains to be clarified and using pre-MSK1p or its mutant version may permit to improve import efficiency for at least some of the constructs.
Expression of tK versions in transmitochondrial cybrid cells bearing the MERRF mutation
The A8344G MERRF mutation affects the tRNA Lys gene encoded in human mtDNA. We wished to determine the effect of expressing importable yeast tRNA Lys on mitochondrial functions in two genetically independent transmitochondrial cybrid MERRF cell lines, M90 and M100, both almost homoplasmic for the mtDNA mutation, and in the relevant wild-type (rhoþ) parental lines (HeLa and 143B, respectively).
Expression of tK3 in M90 and tK93 in M100 cybrids leads to an association of a portion of yeast tRNA derivatives with purified human mitochondria ( Fig. 2A) comparison with the parental cells ( Fig. 2B and C) . Although tK93/3 expression appeared to increase the COX activity, rescue was heterogeneous and an important fraction of the cells in the transfectant pool still retained low levels of enzymatic activity. Since this effect may have been due to differences of levels of expression of transgenes in different clones, we performed further experiment on individual clones of transfectants expressing tK versions at reproducibly stable levels.
Analysis of mitochondrial functions in individual clones of transfected cybrid cells
We selected individual clones of M90 and M100 cells stably expressing and importing tK93 or tK3 with different efficiencies (Fig. 3A) . These clones were still shown to be nearly homoplasmic for the MERRF mutation (.95% of mutant genomes), similar to the original cybrids and individual clones expressing the vector alone (Fig. 3B) . Selected clones were then subjected to a detailed analysis of mitochondrial functions and compared with a series of clonal transfectants containing the empty vector (or the vector containing the pre-MSK1 gene without tRNA genes) and with parental rhoþ cell lines.
Among 50 initially characterized clones, several were analyzed in detail. Three clonal M90 transfectants expressing tK3, three M100 transfectants expressing tK93 and three clones with the vector alone in each line were first analyzed for their substrate-dependent respiration ( Fig. 4A and B) . No detectable effect was found in any clone transfected with the vector alone. In contrast, a clear correlation was found between the amount of imported tRNA and the increased respiration rate for both M90 and M100 transfectants. For clones expressing the highest levels of the yeast tRNAs (M90tK3c2 and M100tK93c7), respiration reached 60 -80% of the wildtype parental cells, which represents a gain of 80 -120% in comparison with the non-transfected cells.
To measure the membrane potential, we used the lipophilic cation methyltriphenyl-phosphonium (TPMP), which is imported into mitochondria as a function of the electrochemical potential across the inner mitochondrial membrane. The loss of inner membrane charge results in a decrease of TPMP binding by digitonin-permeabilized cells (32) . Again, we found that the level of tRNA import coincided with the rescue in membrane potential reaching 70% of the parental lines for the highest tK93 and tK3 expressors (Fig. 4C) .
Respiratory enzymes activity in mitochondrial fractions from various cell lines was also determined. In agreement with previous reports (32), the original cybrid lines showed decreased activities of complexes I and IV, but not markedly for II and III. Expressing tK3 and tK93 in M90 and M100 cells partially rescued activities of complexes I and IV, whereas the same lines transfected with the vector alone exhibited activities similar to those of non-transfected cells (Table 1) .
The MERRF cybrids were reported to be unable to grow on media containing galactose instead of glucose, conditions under which oxidative phosphorylation is required for growth (36) . Therefore we compared the growth rate of transfected and non-transfected cybrid cells on galactosecontaining media (Fig. 5 ). As expected, M90 and M100 cybrids were unable to grow in galactose medium. In contrast, tK3-expressing M90 and tK93-expressing M100 clones were able to propagate, although more slowly than parental cells. (B) Hot-last cycle PCR verification of heteroplasmy levels in individual clones of M90 and M100 transfectants. Digestion with Nae I only cleaves the amplicon containing the A8344G mutation, resulting in two products of 173 and 27 bp. As a cleavage control, all digests were spiked with a 711 bp amplicon carrying a single Nae I site. The cell lines used to isolate DNA are indicated at the top. þ and 0 indicate Nae I-cleaved and non-cleaved PCR products, respectively. This behaviour of the transfectants suggests a rescue of mitochondrial oxidative metabolism due to the import of complementing tRNAs.
Analysis of the translational functionality of imported tRNAs
The MERRF mutation has been reported to lead to a decrease in mitochondrial translation (37) . We also detected a 40 -50% drop of mitochondrial translation rate in M90 and M100 cells (Fig. 6A) . In contrast, expression of tK3 and tK93 partially restored mitochondrial translation (70 -80% of parental lines for the best expressor clones M90tK3c2 and M100tK93c7). This result may indicate that imported tRNAs of yeast origin can pariticipate in human mitochondrial translation.
Depending on the MERRF cell line used, several truncated mitochondrially synthesized polypeptides have been reported (30, 38, 40) . The most abundant product of such abortive translation detected in all cell lines expressing the A8344G mutation was related to Cox1p (38) . When analyzing increased (with respect to control parental cells) amounts of labelled mitochondrially sysnthesized polypeptides on protein gels, we also detected this polypeptide among the products of in vivo mitochondrial translation in M90 and M100 cells (Fig. 6B ). This polypeptide was not detected in parental cell lines, was severely decreased in M100tK93c7 clone (by 80%) and was virtually undetectable in M90tK3c2. This effect was directly related to the levels of yeast tRNA Lys import, since it was not detected either in empty-vector expressing clones, or in clones expressing tK3 or tK93 to low levels (data not shown). This result also is in agreement with our hypothesis that imported tRNAs of cytosolic type may be active in mitochondrial translation.
The rescue of translational defects suggests that yeast tRNA derivatives must be aminoacylated in human mitochondria. To confirm that imported tK versions were aminoacylated, we analyzed mitochondrial tRNA of the transfectants isolated and separated under acidic conditions, to conserve the aminoacyl-tRNAs intacts (41) , by northern hybridization (Fig. 6C) . The difference in migration of the aminoacylated and deacylated forms of tK3 and tK93 extracted from human and yeast mitochondria was similar, suggesting that the yeast tRNAs expressed in human cells may be aminoacylated with lysine, as expected. tK3 was present in the mitochondria essentially in its aminoacylated form; poor resolution of acid-gel analysis for this low expressed version does not permit to be too affirmative, but approximately, .80% of labelled probe was associated with the upper (aminoacylated) form. tK93 version was partially deacylated, only 30% of the tRNA being aminoacylated (Fig. 6C) . If normalized against the host mitochondrial tRNA
Gln , it appears that the level of expression of tK3 in the clone M90tK3c2 was lower than that of tK93 in the clone M100tK93c7. Nevertheless, the amounts of aminoacylated tK3 and tK93 in mitochondria were similar for both clones, in agreement with a comparable rescue of mitochondrial functions.
These experiments permit us to hypothesize that yeast tRNA Lys versions were correctly aminoacylated in human cells, and may function in mitochondrial translation, thus permitting the rescue of defects in mito-translation due to the MERRF mutation. 
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The activities were expressed as nmol/min per mg of mitochondrial protein. To eliminate any changes due to general depletion of mitochondria, the activities of the MERRF cybrids, normalized against citrate synthase activity, were also expressed as a percentage of the normalized activity of the parental cells (HeLa for M90 and 143B for M100 cybrids; k, the coefficient used for correction of all values in relation to citrate synthase activity). The number of independent measures is indicated in parentheses. The statistical significance of all measurements was calculated relative to control cells (HeLa) using Student's unpaired two-tailed t-test. Ã P , 0.05. ÃÃ P , 0.01. Studying the effect of siRNA-mediated downregulation of tK versions onto mitochondrial functions in transfected cybrid clones A corellation of tK3/93 import efficiency with mitochondrial functions rescue is consistent with the hypothesis that the rescue is due to the import of tK versions. To rule out the possibility that the rescue of mitochondrial functions was due to an inadvertent selection of respiratory proficient clones from the original population of transfected cells, downregulation of the expressed tRNAs was attempted with siRNAs in clonal transfectants of cybrid cells. The RNA interference (RNAi) pathway is being extensively exploited for silencing a number of genes in insect, plant and mammalian cells. RNAi is based on an ancient anti-viral defence mechanism found in eukaryotes. It is induced by double-stranded RNAs, which are processed to 21-23 nt small interfering RNAs (siRNAs), that promote the recognition and subsequent degradation of homologous endogenous mRNA (42) (43) (44) (45) . On the other hand, small non-coding RNA molecules may be mediators of a post-transcriptional gene silencing mechanism that regulates the expression of developmental genes, although in this pathway, the translation of mRNAs is affected (46) . It is clear that to affect tRNAs by RNAi only the degradation pathway should be effective.
Having confirmed the efficacy of the siRNA inhibition with the luciferase reporter system (Fig. 7A) , we transiently transfected the clones M90tK3c2 and M100tK93c7 with siRNAs against either tK3 or tK93. Real-time RT -PCR quantification indicated that expression of tK3 and tK93 was specifically inhibited since siRNA against tK3 did not alter the expression of tK93 and vice versa (Fig. 7B) . Our experiments clearly demonstrated that small RNA duplexes can indeed induce specific degradation of tRNAs. We cannot, however, pretend that this approach is efficient enough to achieve silencing of any tRNA, since our targets were transgenic species, which were under-represented in human cultured cells. Nor can we be sure that the exact molecular mechanism of mRNA or tRNA degradation is the same. Nevertheless, we demonstrate for the first time that non-coding RNAs may be affected by dsRNA-induced downregulation as well as messenger RNAs.
Contrary to the impressive downregulation of luciferase activity, mitochondrial parameters were only slightly affected by inhibtion of tK3 and tK93 expression at the day 3 posttransfection (10 -20%). At the day 6, however, we observed a strong specific inhibition of respiration and of the membrane potential, resulting in levels similar to the non-transfected cybrid cells (Fig. 7C and D) . Consistent with reported data We transiently cotransfected the clones M90tK3c2 and M100tK93c7 with the reporter system (pGL3 coding for the luciferase and the siRNA duplex against luciferase mRNA) and with siRNA duplexes against either tK3 or tK93. The presence of the anti-luciferase siRNA strongly inhibited (by 85-90%) the expression of the reporter gene already at day 3 after transfection and this inhibition became almost complete at day 6. HeLa, 143B, M90, M100, M90tK3c2 (3c2) and M100tK93c7 (93c7) without pGL3; 3c2/L and 93c7/L, the clones were transfected with pGL3; 3c2/L/iL and 93c7/L/iL, the clones were co-tansfected with pGL3 and the siRNA against the luciferase mRNA; 3c2/L/iL/i3 and 93c7/L/iL/i93, the clones were co-transfected with pGL3, the siRNA against the luciferase mRNA and either the siRNA against tK3 or that against tK93, respectively. D3 and D6 indicate the number of days after the first transfection (as detailed in Materials and Methods). Luciferase activity was normalized to protein amount and was expressed relative to the positive controls (3c2/L and 93c7/L). (B) Quantification of the tK3 and tK93 by RT-qPCR. Quantification was done as detailed in Materials and Methods and expressed in pg per mg of total or mitochondrial RNA. To quantify, synthetic T7-transcripts were used as controls. The cytosolic tRNA (47), this delayed effect is likely to be due to a low turnover of the mitochondrial respiratory complexes. These experiments provide very strong evidence that the mitochondrial import of tK3 and tK93 is indeed the cause of the rescued mitochondrial functions.
Validation of the tRNA rescue approach in primary patient-derived fibroblasts
Having shown that tRNA import could rescue mitochondrial function in cybrid cells, we wished to determine whether a similar effect could be achieved in a more physiologically relevant cell line. For that purpose we used primary fibroblasts derived from a patient harbouring the A8344G MERRF mutation. As demonstrated by hot-last cycle PCR, these fibroblasts contained 70 + 5% of mutant mtDNA (data not shown). MERRF fibroblasts demonstrated decreased respiration (by 60-70%) and mitochondrial membrane potential (by 70 -80%) in comparison with the fibroblasts of a healthy individual, which is in agreement with previously reported data (32) . As in cybrid cells, transient expression of tK3 and tK93 in human fibroblasts resulted in their partial import into mitochondria (Fig. 8A) . To show the specificity of the rescue effect, we used a tRNA Lys derivative tK1cau as a negative control. This derivative carries a point mutation in the anticodon (Fig. 1A ) that prevents recognition of the lysine codons and, therefore, cannot substitute for the mutant human tRNA Lys in mitochondrial protein synthesis. As expected from the experiments of stable expression described above (Fig. 1) , we observed that tK1cau was indeed imported into fibroblast mitochondria (Fig. 8A) . Expression and import of all transgenic tRNAs were quantified by real-time RT -PCR (Fig. 8B) . As in cybrid cells, tK3 had the lowest expression level, whereas tK93 and tK1cau were expressed and imported with a similar efficiency. The fact that tK3 is expressed at a lower level than tK1cau and tK93 may reflect that its internal promoter is weaker than that in the genes coding for cytosolic tRNAs (see earlier). Transgenic tK versions were significantly under-represented in the cell, in comparison with the host cytosolic and mitochondrial tRNAs. Nevertheless, 10 days after transfection, fibroblasts expressing tK3 and tK93 demonstrated a partial rescue of substrate-dependent respiration and mitochondrial membrane potential (Fig. 8C and D) , contrary to tK1cau, whose expression and mitochondrial import were not accompanied with any detectable rescue. Transfection of healthy fibroblasts with each of the three constructs did not cause significant fluctuation of mitochondrial function, although for some transfectants we did observe a minor decrease (15 -25%) of respiration and membrane potential. We suggest that this minor inhibition may reflect the negative effect of local concentrations of lipofectamine, which appeared to be more toxic to fibroblasts than to the cybrid cells. In spite of this effect, expression of the tK3 and tK93 versions in the MERRF-mutation-harbouring fibroblasts had a significant positive effect on both mitochondrial parameters analyzed.
These data show that tK3 and tK93 import can rescue mitochondrial dysfunctions in primary human cells bearing the MERRF mutation, consistent with the results obtained with immortalized transmitochondrial cybrids.
DISCUSSION
Versatility of RNA import
RNA import into mitochondria, first suggested almost twenty years ago (48) , is now considered as quasi-universal. Found in most important groups of organisms (fungi, protozoans, animals and plants) this pathway seems, however, to share only partial similarity among different species. The differences of RNA import mechanisms among trypanosomatid, plant, human and yeast cells (3, 23) suggest to propose that this pathway may have appeared more than one time during the evolution. It had previously been considered that the absence of some tRNA genes on the mitochondrial genome that were essential for mitochondrial translation indicated that the corresponding tRNA species must be imported from the cytosol (for example, for the trypanosomes lacking any mtDNA-encoded tRNA genes) (49) . However, it has become clear that this criterion is not exhaustive. Indeed, in yeasts a tRNA Lys is imported (tK1), in spite of the presence of an additional tRNA Lys gene in mitochondria (tK3). In plants, in some cases, several isoacceptor tRNAs were shown to be imported, although only a subset may be considered as essential (50, 51) . In this work, we demonstrate that some yeast tRNAs expressed in human cells are partially targeted and imported into mitochondria. Under physiological conditions, tRNA import has not been described in human cells (52, 53) . We therefore suggest that this is a cryptic mechanism that can be activated. The existence of such a mechanism is not so surprising, as other small non-coding RNAs are believed to be mitochondrially imported in human cells (MRP RNA, RNase P RNA and 5S rRNA) (19, 20, 54, 55) , and mitochondrial tRNA import has been suggested for other mammalian species (56). Conversely, preservation of such a mechanism in the cells which have no apparent need of it, may reflect that mitochondrial RNA import has a fundamental importance for the cell. One may propose that such a mechanism may be activated in the case of specific need, either metabolic or genetic. Therefore, the flexibility of the RNA import pathway may provide the cell with one additional adaptive mechanism. It would be of a significant interest to search for possible regulation of RNA import under different conditions of cell growth and in association with different mitochondrial genotypes. Another potentially exploitable aspect of mitochondrial RNA import, more related to the current work, is the possibility to induce tRNA import in human cells, which seems to give a unique opportunity to specifically address 'therapeutic' molecules of nucleic acids into mitochondria.
Transient and stable effects and validity of the model
Two types of cultured human cells were used in this study: transmitochondrial cybrids and primary fibroblasts. Cybrids, being produced by fusion between patient's cytoplasts and immortalized rho zero cells, are genetically aneuploid (57) . On the other hand, cybrids are a convenient model to study the effects of mtDNA mutations on cellular functions in long-term culture, as would be required for producing stably transfected cells. It should also be noted that the vast majority of data exploring the molecular pathogenecity of mitochondrial mutations were obtained using the cybrid technology (58) . Our results clearly show that in cybrids, the various negative effects of the MERFF mutation in the tRNA Lys gene are partially rescued by imported tRNAs of yeast origin, both of cytosolic or mitochondrial type (tK93 and tK3, respectively). This conclusion is based on the following facts: (1) transgene expression and tRNA import correlated with the extent of rescue; (2) two genetically independent cybrid lines showed similar patterns of rescue; (3) an imported mutant version of tK1 that is not able complement the MERRF mutation (tK1cau) did not rescue the mitochondria-deficient phenotype; and (4) downregulation of tK3 and tK93 expression resulted in a specific loss of phenotypic rescue.
Nevertheless, one can argue that various functions (including mitochondrial ones) may be differently affected in cybrids when compared with primary cell lines. To rule out this possibility, we performed similar transfection experiments but with primary cells from a patient harbouring the A8344G transition associated with the MERRF syndrome. Taking into account that primary cells have a limited lifespan, the transfection procedure was performed in conditions favouring transient expression of the transgenes. The conditions used and the time period taken to measure the effects of transient expression was optimized to obtain: (1) a rescue of growth of the transfectants; and (2) a maximal level of expression of the transgene. Transfection procedures for primary cells are known to be rather inefficient and to have strong toxic effects on the cells. Even in our optimized conditions, only 25 -30% of cells survived after the transfection procedure. A period of 8 -10 days was shown to be the minimal time period to allow the cells to divide still retaining robust expression of transgenes. At this time, the expression of tK3 and tK93 clearly had a positive effect on mitochondrial function, whereas tK1cau did not. Taking into account that tK93 and tK1cau were expressed and imported with similar efficiencies, and tK3 with a lesser one (Fig. 8B) , one can conclude that the rescue was specific and due to the import of the yeast tRNA Lys derivatives. These results are in full agreement with the data obtained with the cybrids and therefore suggest that cybrids can be used as a relevant model for developing a gene therapy approach.
Modelling gene therapy by exploiting RNA import pathway
Mutations in the mitochondrial genome are associated with a large spectrum of human diseases (25 -27) . The incidence of each disorder is in the order of 1/10 000, so they can be considered as 'rare'. However, their total number and their chronic progressive nature makes their overall medicoeconomical significance much more impressive. These mutations cause respiratory deficiencies and are associated with various severe and, for a majority of cases, incurable syndromes often with muscular and neurodegenerative and muscular dystrophy manifestations. Point mutations in of the mitochondrial genome are commonly associated with these human pathologies (Wallace and Lott, http://www.mitomap. org). For the vast majority of cases, the molecular consequences of these mutations are unclear and there is no efficient therapy for these disorders. Most deleterious mitochondrial tRNA mutations are heteroplasmic, i.e. mutated mtDNA molecules coexist with wild-type mtDNA molecules. The clinical status of human disorders associated with heteroplasmic mtDNA mutations is greatly dependent on the residual amount of wild-type mtDNA molecules. Clinical symptoms or respiratory chain defects are detected only above a relatively high threshold of mutant mtDNA proportion. As possible tools for therapeutic purposes, we propose to exploit the RNA mitochondrial import pathway, on the basis of artificially developed tRNA targeting into mitochondria of human cells.
Our results demonstrate that specifically designed tRNAs can be addressed into human mitochondria in vivo and, most probably, may be active in mitochondrial translation, thus curing the effect of mutation in a host mitochondrial gene. Such a flexibility of RNA import leads us to propose several modes for complementing mtDNA mutations: to design importable tRNAs with a variety of aminoacylation identities (more than 70 pathogenic point mutations are localized in tRNA genes) (Wallace and Lott, http://www.mitomap.org); to direct into mitochondria suppressor tRNAs to complement missense or nonsense mutations (more than 30 pathogenic cases described); to use imported RNAs as vectors to deliver into mitochondria RNAs with 'therapeutic' activity (for example, interfering with the replication of mutant mtDNA molecules). This last possibility will ideally use the 5S rRNA import pathway, since the efficiency of import (in terms of the number of imported molecules) is much higher than in the case of the artificial tRNA import (15) .
Data described here clearly illustrate the existence of a cryptic tRNA mitochondrial import mechanism in human cells and its potential for alleviating mtDNA mutationinduced mitochondrial defects. This finding may lead to the development of further models of complementation that exploit the RNA import pathway, and may help to provide, in future, a new rationale for therapy of these disorders.
MATERIALS AND METHODS
Plasmid construction
tK1cau, tK93 and tK3 genes were PCR-cloned into Hind III and Eco RI sites of pBK-CMV vector (Stratagene). For expression in S. cerevisiae, the tK93 gene was also PCR-cloned into the Bam HI site of pRS416 vector. All tRNA genes included the sequences found 35 bp upstream and 20 bp downstream of one of the well-expressed tK1 gene copies (59) . Additionally, constructs carried the gene of the yeast mitochondrial lysyl-tRNA synthetase. The full-length MSK1 gene (YNL073w) was PCR-amplified with additional flanking Bcl I site and cloned under control of the CMV promoter in the same vector into Bam HI. The pGL3-control vector (Promega) contained a functional modified luciferase gene (luc þ ) under control of SV40 promoter. Before stable transfection, the plasmids were cleaved by Apa L1. Plasmids were not cleaved for transient transfection.
Cell lines, cultivation and transfection
HeLa cells (Euromedex), HepG2 and 143Brhoþ cells were used as healthy cell controls. Two lines of the MERRF transmitochondrial cybrids used were: M90, derived from HeLa cells and kindly provided by J.-I. Hayashi (University of Tsakuba), which originally contained 90% of mutant genomes, but upon cultivation this line became nearly homoplasmic (.95% of mutant genomes); and the osteosarcoma 143B.206-derived line, M100, kindly provided by E. Schon (Columbia University), original examination of which also revealed nearly total homoplasmy for the MERRF mutation (.95%). Healthy and MERRF mutation containing human fibroblasts were obtained from D. Turnbull, University of Newcastle upon Tyne. Patient fibroblasts harboured 70 + 5% A8344G MERRF mtDNA and, as expected (32) , were strongly affected in mitochondrial functions. Cybrid cells were cultivated in DMEM medium with high glucose (4.5 g/l), sodium pyruvate (110 mg/l) and L-glutamine (2 mM) from Sigma, supplemented with 10% (w : v) fetal calf serum (FCS), 50 mg/ml uridine, standard concentrations of antibiotics (penicillin, streptomycin and fungizone) and, for transfectants, 400 mg/ml of G418. To analyze transfectants for respiration rescue, we used the same medium with 0.9 mg/ml of galactose, which was substituted for glucose. Fibroblasts were cultivated in EMEM medium with nonessential amino acids supplemented with 50 mg/ml of uridine, 1 mM pyruvate and 10% (w : v) FCS. For translation experiments and for testing the growth on galactose, FCS was dialyzed before use. All cell lines were cultivated at 378C and 5% of CO 2 .
Cells were counted in a Neubauer haemocytometer and protein concentrations measured with the Bradford reagent (Bio-Rad). Light microscopy of cell monolayers suggested that non-transfected transmitochondrial MERRF cells and transfectants had similar cell volumes but were smaller than the parental rhoþ cells. However, since the percentage of mitochondrial protein in non-transfected cybrids and in transfectants were comparable (17.4 + 1.5% of total protein in parental cells, 16.3 + 0.9% in M90 cells and 13.8 + 1.9% in M100 cells), we considered that change in size of cells did not affect protein levels of our cellular preparations and that comparison between cell lines was valid.
Stable transfection of cybrid cells was with Superfect reagent (Qiagen) as described by the manufacturer. Stable expression of yeast tRNAs and their mitochondrial import in HepG2 cells had no detectable effect on growth and respiration of transfectants. Transient transfection of cybrids (for RNAi experiment) and of fibroblasts was with Lipofectamine 2000 (Invitrogen) as described by the manufacturer. For cybrid cell transfection we used 70% confluent cells and a 1 : 2.5 ratio of DNA (mg)/Lipofectamine (ml). For fibroblast transfection, 90% confluent cells were used and Lipofectamine concentration was reduced to the ratio 1 : 1 to decrease cytotoxic effects, higher for this type of cells.
Isolation of mitochondria
Mitochondria were isolated as described elsewhere (60) with minor modifications (24) . The integrity of mitochondria was checked by comparison of citrate synthase activities in isotonic medium (0.6 M sorbitol) and hypotonic media (10 mM HEPES-OH, pH 6.8) in the presence of 0.5% (v : v) Triton X-100 as described elsewhere (61) . In all experiments, more than 85% of mitochondria were intact. The absence of contamination of mitochondria with cytosolic RNAs and proteins was confirmed by RT -PCR, quantitative northern hybridization and western analyses as described previously (15, 24) .
Measurement of enzymatic activities, respiration rate and membrane potential
Complex I activity was measured in mitochondria following several cycles of freezing -thawing by the standard procedure and calculated as the rotenone-sensitive NADH : ubiquinone oxidoreductase activity (32) . Complexes II and III (succinate : cytochrome c oxidoreductase) activity was assayed in 50 mM KH 2 PO 4 buffer (pH 7.4) with 1 mM EDTA, 20 mM K-succinate, 2 mM KCN and 10 mM rotenone. The rate of reduction of cytochrome c (50 mM) was measured at 550 nm and the background was measured after addition of myxothiazol to 400 nM. Complex IV activity was measured in 200 mM Tris -HCl (pH 7.5), 10 mM EDTA, 0.3% (v : v) Tween-80, 10 mM rotenone, 300 nM antimycin A 1 , 100 mM ferrocytochrome c at 520 nm, with the background rate measured after addition of KCN (200 mM) (32) .
To measure respiration rate, the cells (0.5 -1 mg of protein) were suspended in 1 ml of 10 mM HEPES -KOH (pH 7.4), 120 mM KCl, 1 mM EGTA, 100 mg/ml of digitonin and either 10 mM succinate with 50 mM rotenone, or 5 mM glutamate with 5 mM malate. O 2 uptake was measured by using a Clark-type oxygen electrode (Strathkelvin Instruments) during 10 min at 378C with sequential addition of oligomycin (25 mM), FCCP (200 nM) and myxothiazol (800 nM) to measure coupled, uncoupled and non-mitochondrial oxygen consumption, respectively. Non-mitochondrial O 2 uptake (ranging between 0.5 and 1.2 nmol/min/mg protein) was subtracted from all values.
Mitochondrial membrane potential was measured in digitonin-permeabilized cells essentially as described (32) . An aliquot of 50 -200 mg of phosphate-buffered saline (PBS)-washed cells were suspended in 200 ml of 10 mM HEPES -KOH (pH 7.4), 120 mM KCl, 1 mM EGTA, 1 mM of (TPMP) iodide, 100 nCi/ml 3 H-TPMP (from NEN, 76 Ci/mmol), 20 mg/ml of digitonin and either 10 mM succinate with 50 mM rotenone, or 5 mM glutamate with 5 mM malate. After 10 min of incubation at 378C, the cells were pelleted and 10 ml aliquots of supernatants and pellets resuspended in 20 ml of 0.5% (v : v) Triton X-100 were counted in a liquid scintillator.Mitochondrial-membrane-independentTPMPaccumulation was measured in parallel incubations in the presence of 400 nM of FCCP and subtracted from all the values. The TPMP uptake was expressed as the ratio between the number of counts (cpm) of TPMP per mg of cellular protein of the pellet and cpm of TPMP per ml of supernatant. Luciferase activity was determined by using the Luciferase Assay System of Promega as described by the supplier. Measurement was done in a scintillation counter and normalized against a positive control (cells transiently transfected with the control pGL3 vector) and expressed in relative units per mg of protein.
Cytochrome c oxidase cytochemistry
For cytochemical analysis, 5 Â 10 5 cells were plated on polylysine treated coverslip, grown for 24 h, washed with PBS and air-dried. Preincubation was performed at room temperature for 15 min in 50 mM Tris -Cl (pH 7.6), 0.28 mg/ml of CoCl 2 . 6H 2 O, 0.5% (v : v) DMSO, 1% sucrose (w : v). After a wash with NPS buffer [0.1 M Na-phosphate (pH 7.6), 10% (w : v) sucrose], the cells were incubated in NPS containing 1 mg/ml of cytochrome c (type IV, Sigma), 1 mg/ml DABhydrochloride, 0.25% (w : v) DMSO, 20 mg/ml catalase for 6 h in the dark. After washing with NPS and PBS, the cells were mounted in DPX and analyzed by optic microscopy. COX-positive cells were counted on anonymized samples. Background was established with a mock colouration of the same cell lines without cytochrome c addition. For each line, we carried out at least five independent counts of more than 500 cells and a mean percentage of +SEM. value was established.
In vivo mitochondrial translation
To analyze mitochondrial translation, 0.5 Â 10 6 of semiconfluent cells were preincubated in RPMI1640 with 0.5% (v : v) of dialyzed FCS lacking methionine and supplemented with 0.2 mg/ml of emetine for 5 min at 378C, followed by 30 min with 200 mCi/ml [ 35 S]-methionine (.1000 Ci/mmol, Amersham), and, finally, with 0.1 mM of non-labelled methionine for a 10 min chase (62) . The cells were PBSwashed, released by PBS -EDTA treatment, disrupted by sonication in 0.1% (v : v) Triton X-100, 10 U/ml of DNAse I, diluted in Laemmli's sample buffer and separated in gradient 10-20% denaturing PAGE. Following visualization with a PhosphorImager (Fuji), quantification was done using the MacBAS v2.5 software. To measure the overall translation activity in mitochondria, the cells suspended in PBS were dissolved by addition of NaOH to 2%, proteins were precipitated with TCA (20%), collected onto millipore filters, washed with 10% of TCA at 708C for 5 min, several times at 08C, once with ethanol, dried and scintillation counted.
Isolation and analysis of mtDNA and RNA Total cellular DNA was isolated by standard procedures (63) and the heteroplasmy level was determined by PCR as described (64) by generating an amplicon with the two oligonucleotides: R8372-8345: GGGGCATTTCACTGTAAAGAGGTGCCGG and F8191-8210: TGTAAAACGACGGCCAGTAAACCAC AGTTTCATGCCCA, a 38-mer carrying 20 residues common to mtDNA 3 0 to sequence from bacteriophage M13 routinely used to prime DNA sequence analysis. Two mismatches (underlined) of the reverse primer contribute to a Nae I site generated with mutant but not wild-type mtDNA. A second pair of primers was used to generate an amplicon to control for Nae I digestion: F516 -534: CACACACACCGCTGCTAAC and R1190-1172: GATATGAAGCACCGCCAGG. PCR-amplified fragments were 32 P-labelled during an additional cycle of polymerization, cut with Nae I and analyzed on 10% non-denaturing polyacrylamide gels and PhosphorImaging.
Mitochondrial RNA was isolated with Trizol-reagent (Invitrogen) by standard procedures and analyzed by northern hybridization as previously described (24) . To analyze aminoacylation in vivo, mtRNA was isolated in acid conditions, separated in 0.1 M sodium acetate (pH 4.8, 6.5% PAGE as described elsewhere (41) and analyzed by hybridization. To detect tK3, we used the oligonucleotide probe antiK3 (1 -39): CTTAAAAGACAACTGTTTTACCATTAAACAAT ATTCTC; for tK93, the probe antiK2 (2 -32): GCCGAAC GCTCTACCAACTCAGCTAACAAGG, for tK1cau, the probe antitK1(met): CTTATGATTATGAGTCAT; for human cytosolic tRNA Met i , the probe anti-cM: TGGTAGCAGAGGATGG TTTCG, for human mitochondrial tRNA Gln , anti-mQ: CTA GGACTATGAGAATCG.
For RT -PCR detection of tRNAs, we used the following pairs of oligonucleotides ('f' for forward and 'r' for reverse). For tK93, t93f: CTTGTTAGCTCAGTTGGT and t93r: TGGA GCCTCATAGGGGGC; for tK3, t3f: GAGAATATTGTTT AATGGTAAAAC and t3r: GGTGAGAATAGCTGGAGTT G; for tK1cau, t1f: GCCTTGTTGGCGCAATCGG and t1r: GGAGCCCTGTAGGGGGCTCG; for mitochondrial tRNA Gln , hMQr: TAGGACTATGAGAATCG and hMQf: AGGAT GGGGTGTGATAG; for cytoplasmic tRNA Met i , hCMr: GGT AGCAGAGGATGGTTTCG and hCMf: CAGAGTGGCGC AGCGGAAG. Amplification was done by using the single-step RT -PCR kit of Qiagen in the following conditions: 508C, 30 min; 958C, 15 min, 15 cycles at 95 -55 -728C, 10 cycles at 95-58 -728C and 5 cycles at 95 -62 -728 (each step for 1 min), with the final step at 728C for 10 min. In all cases, a control PCR was included, performed in similar conditions as RT -PCR by Taq DNA polymerase, to confirm the absence of DNA contamination in RNA isolates. Quantitative (real-time) RT -PCR was done using a BioRad i-Cycler with the One-Step RT -qPCR Mastermix for SYBR green I (Eurogentec). For RT -qPCR, conditions were similar as above, but the number of the cycles at 588C was increased to 25. For quantitation, serial RNA dilutions were done and compared with the calibration curve obtained in parallel reactions with a series of diluted gel-purified T7-transcripts (tK1, tK3 or tK93), ranging from 0.1 to 10 ng per reaction. All qPCR samples were done in three parallels and the +SEM values were less than 5% in each case.
RNA interference
siRNA duplexes, 21 and 22 nt long, with symmetric 2 nt 3 0 overhangs directed against the reporter gene (luciferase ), tK3 and tK93 were purchased from Genset. The following oligoribonucleotides were used. LucSiF: GGAUUCUAAAA CGGAUUACCdTdT and LucSiR: GGUAAUCCGUUUUA GAAUCCdTdT for luciferase (forward and reverse, respectively, correspond to the region 456 -476 of the luciferase coding ORF in pGL3); t93SiF: GGCUUUUAACCGAAAUG UCdTdT and t93SiR: GACAUUUCGGUUAAAAGCCdTdT for tK93 (the region 30-48 of the tRNA); t3SiF: GUUGU CUUUUAAGCAACCCdTdT and t3SiR: GGGUUGCUU AAAAGACAACdTdT (the region 26 -44 of the tRNA). The 2 nt 3 0 ovehangs represented two 2 0 -deoxythymidine residues (dT). Upon transfection with Lipofectamine 2000 reagent (Invitrogen), we used siRNA duplexes at 50 nM. An aliquot of 5 mg of uncut pGL3 was used in co-transfection experiments per one 10 cm 2 well. This ratio DNA:siRNA was sufficient for a nearly full inhibition of luciferase activity. The day after transfection, the medium without antibiotics was replaced by the same madium with G418. At day 3 after transfection, one half of the samples were subjected to a second round of transfection in the same conditions as initially. At the days 3 and 6, the cells were detached and analyzed for RNA concentrations (by RT -qPCR), luciferase activity, mitochondrial membrane potential and respiration.
